Alberto Verlicchi
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 19
- Lung Cancer Research Studies 6
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
-
- Lung Cancer Treatments and Mutations 15
- Co-authors
- R Cebolla Rosell (7 shared papers)Paola Ulivi (12 shared papers)Jordi Codony‐Servat (2 shared papers)Angelo Delmonte (11 shared papers)Lucio Crinò (12 shared papers)Giuseppe Bronte (8 shared papers)Paola Cravero (7 shared papers)Niki Karachaliou (6 shared papers)
In The Last Decade
Alberto Verlicchi
23 papers receiving 724 citations
Peers
Comparison fields: 5 of 64
- Oncology 342
- Pulmonary and Respiratory Medicine 331
- Cancer Research 134
- Molecular Biology 262
- Pathology and Forensic Medicine 51
Countries citing papers authored by Alberto Verlicchi
This map shows the geographic impact of Alberto Verlicchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alberto Verlicchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alberto Verlicchi more than expected).
Fields of papers citing papers by Alberto Verlicchi
This network shows the impact of papers produced by Alberto Verlicchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alberto Verlicchi. The network helps show where Alberto Verlicchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Alberto Verlicchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 192 | |
| 2 | 2015 | 78 | |
| 3 | 2016 | 73 | |
| 4 | 2020 | 62 | |
| 5 | 2015 | 58 | |
| 6 | 2019 | 55 | |
| 7 | 2019 | 35 | |
| 8 | 2016 | 28 | |
| 9 | Targeting RET-rearranged non-small-cell lung cancer: future prospects | 2019 | 26 |
| 10 | 2014 | 25 | |
| 11 | 2019 | 20 | |
| 12 | 2023 | 17 | |
| 13 | 2019 | 14 | |
| 14 | 2012 | 12 | |
| 15 | 2017 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2016 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About Alberto Verlicchi
Alberto Verlicchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Immunology, having authored 25 papers that have together received 733 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (15 papers), Lung Cancer Research Studies (6 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Cells and Metastasis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (3 papers), Quinazolinone synthesis and applications (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (342 citations), Pulmonary and Respiratory Medicine (331 citations), Cancer Research (134 citations), Molecular Biology (262 citations) and Pathology and Forensic Medicine (51 citations). Alberto Verlicchi has collaborated with scholars based in Italy, Spain and China. Frequent co-authors include R Cebolla Rosell, Paola Ulivi, Jordi Codony‐Servat, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Paola Cravero, Niki Karachaliou, Maximilian Papi and Elisa Chiadini. Their work appears in journals such as Journal of Thoracic Oncology, International Journal of Molecular Sciences, Clinical Lung Cancer, Future Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.